Total Non-Current Liabilities

$16.45B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$19.38Bperiod endingDec 31, 2025

TEVA FY Total Non-Current Liabilities ($45.60M → $19.38B)

Annual total non-current liabilities

High-resolution chart · PNG

TEVA total non-current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Total Non-Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Non-Current Liabilities (USD)
Dec 31, 2025	19,377,700,000
Dec 31, 2024	20,810,000,000
Dec 31, 2023	23,106,000,000
Dec 31, 2022	23,944,000,000
Dec 31, 2021	25,395,000,000
Dec 31, 2020	26,415,000,000
Dec 31, 2019	28,733,000,000
Dec 31, 2018	30,567,000,000
Dec 31, 2017	33,949,000,000
Dec 31, 2016	39,378,000,000
Dec 31, 2015	11,326,000,000
Dec 31, 2014	10,776,000,000
Dec 31, 2013	12,907,000,000
Dec 31, 2012	14,854,000,000
Dec 31, 2011	13,952,000,000
Dec 31, 2010	7,156,000,000
Dec 31, 2009	6,949,000,000
Dec 31, 2008	8,063,000,000
Dec 31, 2007	4,281,000,000
Dec 31, 2006	5,223,000,000
Dec 31, 2005	2,077,000,000
Dec 31, 2004	2,028,300,000
Dec 31, 2003	924,900,000
Dec 31, 2002	1,268,300,000
Dec 31, 2001	1,339,190,000
Dec 31, 2000	918,880,000
Dec 31, 1999	434,147,000
Dec 31, 1998	238,800,000
Dec 31, 1997	148,000,000
Dec 31, 1996	184,500,000
Dec 31, 1995	62,000,000
Dec 31, 1994	93,800,000
Dec 31, 1993	84,300,000
Dec 31, 1992	52,100,000
Dec 31, 1991	70,700,000
Dec 31, 1990	91,600,000
Dec 31, 1989	86,100,000
Dec 31, 1988	58,400,000
Mar 31, 1987	38,900,000
Mar 31, 1986	45,600,000